Maryland Code § SG-6.5-301

Section SG-6.5-301
Open in Lexace · Ask the AI about this section
(a) The appropriate regulating entity may not approve an acquisition
unless it finds the acquisition is in the public interest.
(b) An acquisition is not in the public interest unless appropriate steps have
been taken to:
(1) ensure that the value of public or charitable assets is safeguarded;
(2) ensure that the value of public or charitable assets is spent in a
manner that corresponds with the potential risk associated with the acquisition;
(3) ensure that:
(i) the fair value of the public or charitable assets of a
nonprofit health service plan or a health maintenance organization will be distributed
to the Maryland Health Care Trust established under § 6.5-401 of this title; or
(ii) 1. 40% of the fair value of the public or charitable
assets of a nonprofit hospital will be distributed to the Maryland Health Care Trust
established under § 6.5-401 of this title; and

2. 60% of the fair value of the public or charitable
assets of a nonprofit hospital will be distributed to a public or nonprofit charitable
entity or trust that is:
A. dedicated to serving the unmet health care needs of
the affected community;
B. dedicated to promoting access to health care in the
affected community;
C. dedicated to improving the quality of health care in
the affected community; and
D. independent of the transferee;
(4) ensure that no part of the public or charitable assets of the
acquisition inure directly or indirectly to an officer, director, or trustee of a nonprofit
health entity; and
(5) ensure that no officer, director, or trustee of the nonprofit health
entity receives any immediate or future remuneration as the result of an acquisition
or proposed acquisition except in the form of compensation paid for continued
employment with the acquiring entity.
(c) The regulating entity may determine that a distribution of assets of a
nonprofit health entity is not required under this section if the transaction is:
(1) determined not to be an acquisition;
(2) in the ordinary course of business; and
(3) for fair value.
(d) In determining fair value, the appropriate regulating entity may
consider all relevant factors, including, as determined by the regulating entity:
(1) the value of the nonprofit health entity or an affiliate or the assets
of such an entity that is determined as if the entity had voting stock outstanding and
100% of its stock was freely transferable and available for purchase without
restriction;
(2) the value as a going concern;
(3) the market value;

(4) the investment or earnings value;
(5) the net asset value; and
(6) a control premium, if any.
(e) (1) In determining whether an acquisition is in the public interest,
the appropriate regulating entity shall consider:
(i) whether the transferor exercised due diligence in deciding
to engage in an acquisition, selecting the transferee, and negotiating the terms and
conditions of the acquisition;
(ii) the procedures the transferor used in making the decision,
including whether appropriate expert assistance was used;
(iii) whether any conflicts of interest were disclosed, including
conflicts of interest of board members, executives, and experts retained by the
transferor, transferee, or any other parties to the acquisition;
(iv) whether the transferor will receive fair value for its public
or charitable assets;
(v) whether public or charitable assets are placed at
unreasonable risk if the acquisition is financed in part by the transferor;
(vi) whether the acquisition has the likelihood of creating a
significant adverse effect on the availability or accessibility of health care services in
the affected community;
(vii) whether the acquisition includes sufficient safeguards to
ensure that the affected community will have continued access to affordable health
care; and
(viii) whether any management contract under the acquisition
is for fair value.
(2) In determining whether a nonprofit health entity has exercised
due diligence as required under paragraph (1)(i) of this subsection, the appropriate
regulating entity may not determine that due diligence was exercised unless the
nonprofit health entity considered the risks of an acquisition, including whether an
acquisition:

(i) would result in diseconomies of scale; or
(ii) would violate federal or State antitrust laws.
(f) The public or charitable assets distributed to a public or nonprofit
charitable entity or trust in accordance with subsection (b)(2) of this section shall be
in the form of cash.
(g) The appropriate regulating entity shall determine whether a payment
by a nonprofit health entity, required under an agreement or contract for the
acquisition of a nonprofit health entity if the agreement or contract is broken by the
nonprofit health entity, is in the public interest.

‹ Prev All Maryland sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.